Volume 19, Issue 8
August 2017
Cover image
Cover image
Detail from Figure 3 of the article “The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas” by Anderson, Muraleedharan, Oatman et al beginning on p. 1068.
ISSN 1522-8517
EISSN 1523-5866
Issue navigation
Volume 19, Issue 8, August 2017
Editorials
Prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1015–1016, https://doi.org/10.1093/neuonc/nox113
Lessons learned from diffuse intrinsic pontine glioma: how a terrible disease forced us to think better
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1017–1018, https://doi.org/10.1093/neuonc/nox022
A search for the “Goldilocks zone” with regard to the optimal duration of adjuvant temozolomide in patients with glioblastoma
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1019–1020, https://doi.org/10.1093/neuonc/nox046
Highlights from the Literature
Highlights from the Literature
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1021–1024, https://doi.org/10.1093/neuonc/nox114
Reviews
Diffuse intrinsic pontine gliomas—current management and new biologic insights. Is there a glimmer of hope?
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1025–1034, https://doi.org/10.1093/neuonc/nox021
Sleep disturbance of adults with a brain tumor and their family caregivers: a systematic review
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1035–1046, https://doi.org/10.1093/neuonc/nox019
Basic and Translational Investigations
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1047–1057, https://doi.org/10.1093/neuonc/nox026
Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1058–1067, https://doi.org/10.1093/neuonc/now309
The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1068–1078, https://doi.org/10.1093/neuonc/now299
Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1079–1087, https://doi.org/10.1093/neuonc/now300
Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1088–1096, https://doi.org/10.1093/neuonc/nox018
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1097–1108, https://doi.org/10.1093/neuonc/now304
Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1109–1118, https://doi.org/10.1093/neuonc/nox016
Clinical Investigations
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1119–1126, https://doi.org/10.1093/neuonc/nox025
Characteristics of H3 K27M-mutant gliomas in adults
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1127–1134, https://doi.org/10.1093/neuonc/now274
Pediatric Neuro-Oncology
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1135–1144, https://doi.org/10.1093/neuonc/now282
Letter to the Editor
The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity
Neuro-Oncology, Volume 19, Issue 8, August 2017, Pages 1145–1146, https://doi.org/10.1093/neuonc/nox043
Society News
Forthcoming Meetings
Neuro-Oncology, Volume 19, Issue 8, August 2017, Page 1147, https://doi.org/10.1093/neuonc/nox118
